Search results for "MCF-7 Cell"

showing 10 items of 104 documents

A fully synthetic glycopeptide antitumor vaccine based on multiple antigen presentation on a hyperbranched polymer.

2014

For antitumor vaccines both the selected tumor-associated antigen, as well as the mode of its presentation, affect the immune response. According to the principle of multiple antigen presentation, a tumor-associated MUC1 glycopeptide combined with the immunostimulating T-cell epitope P2 from tetanus toxoid was coupled to a multi-functionalized hyperbranched polyglycerol by "click chemistry". This globular polymeric carrier has a flexible dendrimer-like structure, which allows optimal antigen presentation to the immune system. The resulting fully synthetic vaccine induced strong immune responses in mice and IgG antibodies recognizing human breast-cancer cells.

GlycerolSynthetic vaccinePolymersAntigen presentationEpitopes T-LymphocyteBreast NeoplasmsCancer VaccinesCatalysisEpitopeAntibodiesMiceImmune systemAntigenAntigens NeoplasmTetanus ToxoidOrganic chemistryAnimalsHumansAntigen PresentationbiologyChemistryOrganic ChemistryMucin-1ToxoidGlycopeptidesGeneral ChemistryGlycopeptideImmunologybiology.proteinMCF-7 CellsClick ChemistryFemaleAntibodyChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3 CysSerLys4.

2016

The Toll-like receptor 2 ligand Pam3 CysSer is of particular interest for the construction synthetic vaccines because of its ability to stimulate of the innate immune system. Such vaccines usually comprise Pam3 CysSer with the natural R-configuration at the glycerol 2-position. Pam3 CysSer peptide vaccines with natural configuration have been shown to be more efficient than the corresponding R/S diastereomers. In order to clarify whether the effect of the configuration of Pam3 Cys on the immune response also applies to glycopeptide vaccines, MUC1 glycopeptide-lipopeptide vaccines bearing either R- or R/S-configured Pam3 CysSerLys4 were compared for their immunological effects. In order to f…

GlycosylationGlycosylationLipoproteins010402 general chemistry01 natural sciencesBiochemistryCancer VaccinesEpitopechemistry.chemical_compoundMiceImmune systemAnimalsHumansMolecular BiologyMUC1Solid-Phase Synthesis TechniquesMice Inbred BALB CVaccines SyntheticInnate immune systembiology010405 organic chemistryOrganic ChemistryMucin-1GlycopeptidesImmunityLipopeptideStereoisomerismVirologyGlycopeptide0104 chemical scienceschemistrybiology.proteinMCF-7 CellsMolecular MedicineAntibodyChembiochem : a European journal of chemical biology
researchProduct

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.

2021

ABSTRACTTherapeutic targeting of the estrogen receptor (ER) is a clinically validated approach for estrogen receptor positive breast cancer (ER+ BC), but sustained response is limited by acquired resistance. Targeting the transcriptional coactivators required for estrogen receptor activity represents an alternative approach that is not subject to the same limitations as targeting estrogen receptor itself. In this report we demonstrate that the acetyltransferase activity of coactivator paralogs CREBBP/EP300 represents a promising therapeutic target in ER+ BC. Using the potent and selective inhibitor CPI-1612, we show that CREBBP/EP300 acetyltransferase inhibition potently suppresses in vitro…

Hepatocyte Nuclear Factor 3-alphaMultidisciplinaryReceptors EstrogenAcetyltransferasesCell Line TumorMCF-7 CellsHumansBreast NeoplasmsFemaleCREB-Binding ProteinE1A-Associated p300 ProteinCell ProliferationPloS one
researchProduct

Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications

2012

11 páginas, 7 figuras, 3 tablas y 2 esquemas

INGENIERIA DE LA CONSTRUCCIONCell SurvivalPyridinesmedia_common.quotation_subjectenzymesNanoparticleNanotechnologyPyridinium Compoundsmesoporous materialsCatalysisgated materialsHeLachemistry.chemical_compoundQUIMICA ORGANICAQUIMICA ANALITICAmedicineRhodamine BHumansGated materialsInternalizationAzopyridinium derivativemedia_commonbiologyChemistryRhodaminesOrganic ChemistryQUIMICA INORGANICAGeneral Chemistrybiology.organism_classificationSilicon DioxideCombinatorial chemistryMesoporous materialsEnzymesazopyridinium derivativeDrug deliveryDrug deliveryMCF-7 CellsNanoparticlesnanoparticlesMesoporous materialOxidoreductasesAzo CompoundsPorosityCamptothecinIntracellularmedicine.drugHeLa Cells
researchProduct

Amidase-responsive controlled release of antitumoral drug into intracellular media using gluconamide-capped mesoporous silica nanoparticles

2012

MCM-41 silica nanoparticles were used as inorganic scaffolding to prepare a nanoscopic-capped hybrid material S1, which was able to release an entrapped cargo in the presence of certain enzymes, whereas in the absence of enzymes, a zero release system was obtained. S1 was prepared by loading nanoparticles with Safranine O dye and was then capped with a gluconamide derivative. In the absence of enzymes, the release of the dye from the aqueous suspensions of S1 was inhibited as a result of the steric hindrance imposed by the bulky gluconamide derivative, the polymerized gluconamide layer and the formation of a dense hydrogen-bonded network around the pore outlets. Upon the addition of amidase…

INGENIERIA DE LA CONSTRUCCIONMaterials scienceCell SurvivalNanoparticleAntineoplastic AgentsElectron Microscopy Service of the UPVGluconatesAmidaseAmidohydrolasesHydrolysisQUIMICA ORGANICAEnzymatic hydrolysisPeptide bondOrganic chemistryHumansGeneral Materials ScienceDrug effectsMicroscopy ConfocalQUIMICA INORGANICAHydrogen BondingMesoporous silicaSilicon DioxideControlled releaseCombinatorial chemistryMCF-7 CellsNanoparticlesCamptothecinHybrid materialLysosomesPorosityHeLa Cells
researchProduct

Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticles.

2013

Dual targeted drug delivery systems represent a potential platform for developing efficient vector to tumor sites. In this study we evaluated a folate- and magnetic-targeted nanocarriers based on 10 nm iron oxide nanodomais coated with the properly synthesized and characterized folic acid (FA)-functionalized amphiphilic copolymer PHEA-PLA-PEG-FA. FA was chemically conjugated to one end of diamino-polyethylene glycol of 2000 Da, in order to ensure its exposition on the polymer coated magnetic nanoparticles (MNPs-FA). The prepared nanoparticles have been exhaustively characterized by different methods, including DLS, SEM, FT-IR and magnetic measurements. Magnetic nanoparticles showed dimensio…

IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; COPOLYMERSPolymersmedia_common.quotation_subjectBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)NanoparticleBioengineeringFolic AcidCoated Materials BiocompatibleCell Line TumorMaterials TestingHumansGeneral Materials ScienceViability assayMolecular Targeted TherapyInternalizationMagnetite Nanoparticlesmedia_commonChemistryNeoplasms Experimentalequipment and suppliesTreatment OutcomeTargeted drug deliveryCancer cellBiophysicsMCF-7 CellsMagnetic nanoparticlesNanocarriershuman activitiesFolate Targeting; Magnetic Nanoparticles; Cell Uptake; Ferrozine Assay; Polymer CoatingSuperparamagnetismJournal of biomedical nanotechnology
researchProduct

Subcellular duplex DNA and G‐quadruplex interaction profiling of a hexagonal PtII metallacycle

2019

[Abstract] Metal‐driven self‐assembly afforded a multitude of fascinating supramolecular coordination complexes (SCCs) with applications as catalysts, host–guest, and stimuli‐responsive systems. However, the interest in the biological applications of SCCs is only starting to emerge and thorough characterization of their behavior in biological milieus is still lacking. Herein, we report on the synthesis and detailed in‐cell tracking of a Pt2L2 metallacycle. We show that our hexagonal supramolecule accumulates in cancer cell nuclei, exerting a distinctive blue fluorescence staining of chromatin resistant to UV photobleaching selectively in nucleolar G4‐rich regions. SCC co‐localizes with epit…

KeratinocytesModels MolecularOrganoplatinum CompoundsmetallacycleSupramolecular chemistry010402 general chemistryG-quadruplex01 natural sciencesCatalysisEpitopeMetallacycleCell Line Tumorsubcellular localizationHumansplatinumPlatinumG-quadruplex010405 organic chemistryHexagonal crystal systemChemistrySubcellular localizationCommunicationDNAGeneral ChemistryFibroblastsMetallacycleSubcellular localizationPhotobleachingCommunicationsSCC0104 chemical sciencesChromatinG-QuadruplexesSettore CHIM/03 - Chimica Generale E InorganicaMCF-7 CellsBiophysicsSpectrophotometry Ultraviolet
researchProduct

Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.

2013

The obesity hormone leptin has been implicated in breast cancer development. Breast cancer cells express the leptin receptor and are able to synthesize leptin in response to obesity-related stimuli. Furthermore, leptin is a positive regulator of vascular endothelial growth factor (VEGF) and high levels of both proteins are associated with worse prognosis in breast cancer patients. Peroxisome proliferator-activated receptor γ (PPARγ) ligands are therapeutic agents used in patient with Type 2 diabetes and obesity which have recently been studied for their potential anti-tumor effect. Here, we studied if these compounds, ciglitazone and GW1929, can affect the expression of leptin and VEGF in b…

LeptinVascular Endothelial Growth Factor APhysiologySettore MED/06 - Oncologia MedicaClinical BiochemistryLigandschemistry.chemical_compoundCell MovementPromoter Regions Geneticskin and connective tissue diseasesReceptorGENE-EXPRESSIONLeptindigestive oral and skin physiologyVEGFGene Expression Regulation NeoplasticVascular endothelial growth factorROSIGLITAZONEACTIVATED-RECEPTOR-GAMMAMCF-7 CellsPIOGLITAZONEFemalemedicine.medical_specialtyCell SurvivalSp1 Transcription FactorBLADDER-CANCERBreast NeoplasmsBiologyBenzophenonesBreast cancerCiglitazoneInternal medicinemedicineHumansRNA MessengerViability assayBinding SitesLeptin receptorDose-Response Relationship DrugCell BiologyIN-VITROmedicine.diseaseTRANSACTIVATIONDIABETIC-PATIENTSPPAR gammaEndocrinologychemistryTyrosineTHIAZOLIDINEDIONESACTIVATED-RECEPTOR-GAMMA; BLADDER-CANCER; IN-VITRO; DIABETIC-PATIENTS; GENE-EXPRESSION; VEGF; PIOGLITAZONE; THIAZOLIDINEDIONES; TRANSACTIVATION; ROSIGLITAZONEHormone
researchProduct

Synthesis and Anti-Tumor Activity of Novel Aminomethylated Derivatives of Isoliquiritigenin

2014

A series of new aminomethylated derivatives of isoliquiritigenin was synthesized. The structures of the compounds were confirmed by IR, MS, NMR, 13C-NMR and elemental analyses. Cytotoxic activities of these derivatives towards the human prostatic cell line PC-3, human mammary cancer cell line MCF-7 and human oophoroma cell line HO-8910 in vitro were tested. The IC50 values showed cytotoxic activities of some of these new derivatives were relatively strong. Furthermore, tumor growth inhibition in vivo of aminomethylated derivatives of isoliquiritigenin 15 was superior to that of isoliquritigenin and reached inhibition rates of 71.68%. The detailed synthesis, spectroscopic data, biological an…

Magnetic Resonance SpectroscopyPharmaceutical ScienceAntineoplastic AgentsArticleAnalytical Chemistrylcsh:QD241-441MiceStructure-Activity Relationshipchemistry.chemical_compoundChalconeslcsh:Organic chemistryIn vivoCell Line TumorDrug DiscoveryMannich reactionAnimalsHumansStructure–activity relationshipCytotoxic T cellPhysical and Theoretical ChemistryMannich reactionCell ProliferationMice Inbred BALB COrganic Chemistryorganic synthesisIn vitrochemistryBiochemistryChemistry (miscellaneous)Cell cultureaminomethylated derivatives of isoliquiritigeninMCF-7 CellsMolecular MedicineFemaleOrganic synthesisanti-tumor activityDrug Screening Assays AntitumorIsoliquiritigeninMolecules
researchProduct

Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions : a study on postmenopausal mo…

2014

MiRNAs are fine-tuning modifiers of skeletal muscle regulation, but knowledge of their hormonal control is lacking. We used a co-twin case-control study design, that is, monozygotic postmenopausal twin pairs discordant for estrogen-based hormone replacement therapy (HRT) to explore estrogen-dependent skeletal muscle regulation via miRNAs. MiRNA profiles were determined from vastus lateralis muscle of nine healthy 54-62-years-old monozygotic female twin pairs discordant for HRT (median 7 years). MCF-7 cells, human myoblast cultures and mouse muscle experiments were used to confirm estrogen's causal role on the expression of specific miRNAs, their target mRNAs and proteins and finally the act…

MaleMICRORNASMonozygotic twinmenopausePATHWAYMice0302 clinical medicineMyocyteInsulin-Like Growth Factor IIN-VIVO0303 health sciencesphosphorylationAge FactorsBREAST-CANCER CELLSWOMENMiddle Aged3142 Public health care science environmental and occupational healthPostmenopauseESTROGENmedicine.anatomical_structureMCF-7 CellsmTORGROWTHFemaleAUTOPHAGYMESSENGER-RNASignal TransductionIGF-1 receptormedicine.medical_specialtyHormone Replacement Therapymedicine.drug_classmiR-142-3pBiology03 medical and health sciencesInternal medicinemicroRNAmedicineAnimalsHumansMuscle SkeletalProtein kinase BPI3K/AKT/mTOR pathwayAged030304 developmental biologyAKTagingSkeletal muscleOriginal ArticlesTwins MonozygoticCell BiologyAKT; FOXO3A; IGF-1 signaling; IGF-1R; aging; mTOR; menopause; miR-142-3p; miR-182; miR-223; phosphorylationmiR-223EndocrinologyEstrogenCase-Control StudiesmiR-1823121 General medicine internal medicine and other clinical medicineFOXO3AIGF-1 signalingIGF-1R030217 neurology & neurosurgeryHUMAN LONGEVITYHormone
researchProduct